ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,482, issued on Feb. 17, was assigned to The Regents of the University of California (Oakland, Calif.).
"Aurora kinase inhibitors" was invented by Justin Gabriel Meyerowitz (San Francisco), William Clay Gustafson (San Francisco), William A. Weiss (San Francisco), Nicholas T. Hertz (San Francisco) and Kevan M. Shokat (San Francisco).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein inter alia are compositions and methods useful in the treatment of cancer and for modulating the activity of Aurora A kinase and/or a Myc family protein."
The patent was filed on Aug. 30, 2021, under Application No. 17/461,616.
*For further information, inclu...